Tempest Therapeutics, Inc. Proceeds from Issuance of Private Placement
Tempest Therapeutics, Inc. (TPST) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2021-03-29
- Tempest Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2020 was $0.00.
- Tempest Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2019 was -$15.00K, a 100.04% decline from fiscal 2018.
- Tempest Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2018 was $38.76M.
| Period end | Proceeds from Issuance of Private Placement 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 |
| 2019-12-31 | -$15.00K 10-K · filed 2021-03-29 |
| 2018-12-31 | $38.76M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |